샘플 요청 목록

 카트 문의
시장보고서
상품코드
1761081

안정동위원소 표지 화합물 시장

Stable Isotope Labeled Compounds
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 408 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

안정동위원소 표지 화합물 세계 시장은 2030년까지 4억 3,250만 달러에 달할 전망

2024년에 3억 4,350만 달러로 추정되는 안정동위원소 표지 화합물 세계 시장은 2024년부터 2030년까지 CAGR 3.9%로 성장하여 2030년에는 4억 3,250만 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석되고 있는 부문 중 하나인 중수소는 CAGR 4.9%를 기록하며 분석 기간 종료시에는 1억 8,340만 달러에 달할 것으로 예상됩니다. 산소-18 부문의 성장률은 분석 기간 동안 CAGR 4.0%로 추정됩니다.

미국 시장은 1억 2,900만 달러로 추정, 중국은 CAGR 6.1%로 성장 예측

미국의 안정동위원소 표지 화합물 시장은 2024년에 1억 2,900만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 분석 기간인 2024-2030년 CAGR 6.1%로 2030년까지 3,300만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 2.7%와 3.7%로 예측됩니다. 유럽에서는 독일이 CAGR 3.4%로 성장할 것으로 예측됩니다.

세계의 안정동위원소 표지 화합물 시장 - 주요 동향과 촉진요인 정리

안정동위원소 표지 화합물은 의약품, 환경 조사, 대사 연구 등 다양한 과학 및 산업 응용 분야에서 중요한 도구입니다. 탄소13, 질소15, 산소18, 중수소와 같은 비방사성동위원소로 표지된 이들 화합물은 연구자들이 복잡한 생화학적, 화학적 과정을 정밀하게 추적하고 조사할 수 있게 해줍니다. 안정동위원소를 사용하면 반응 메커니즘, 대사 경로, 약물 상호 작용에 대한 자세한 인사이트를 제공하여 생물학적 시스템 및 환경 역학에 대한 이해를 크게 향상시킬 수 있습니다. 방사성동위원소와 달리 안정동위원소는 방사선의 위험이 없기 때문에 실험실 및 산업 환경에서 광범위하게 사용할 때 더 안전하고 다재다능합니다.

안정동위원소 표지 화합물 시장은 의약품 연구개발에 대한 수요 증가로 인해 확대되고 있습니다. 이들 화합물은 신약의 합성 및 시험에 필수적이며, 치료제의 약동학 및 대사 운명을 결정하는 데 도움이 됩니다. 환경 과학 분야에서 안정동위원소는 영양 순환, 탄소 흐름, 오염원 추적에 사용되어 생태학적 연구와 환경 모니터링에 필수적인 데이터를 제공합니다. 핵자기공명(NMR), 질량분석 등 첨단 분석 기술의 등장으로 안정동위원소 표지 화합물의 유용성은 더욱 높아져 보다 정밀하고 종합적인 분석이 가능해졌습니다.

안정동위원소 표지 화합물 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다. 첫째, 의약품 연구개발에 대한 투자 증가로 인해 의약품 개발 및 대사 연구 분야에서 이러한 화합물에 대한 수요가 증가하고 있습니다. 둘째, 질량 분석 및 NMR의 감도와 분해능 향상과 같은 분석 기술의 발전으로 인해 안정동위원소 표지 화합물의 용도가 확대되고 있습니다. 셋째, 환경 지속가능성에 대한 관심의 증가와 정확한 생태학적 모니터링의 필요성이 환경 연구에서 안정동위원소의 사용을 촉진하고 있습니다. 마지막으로, 의약품 승인 과정에서 상세한 대사 및 약동학 데이터에 대한 규제 요건이 시장 성장을 더욱 촉진하고 있습니다. 이러한 요인들이 종합적으로 안정동위원소 표지 화합물 시장의 견조한 성장에 기여하고 있습니다.

부문

유형(중수소, 산소-18, 탄소-13, 질소-15, 기타 유형), 최종사용자(제약·바이오테크놀러지 기업, 학술·연구기관, 병원·진단 센터, 기타 최종사용자)

조사 대상 기업 사례(총 73개사)

  • 3M Company
  • Charles River Laboratories International, Inc.
  • American Elements
  • Bio-Techne Corporation
  • Cambridge Isotope Laboratories, Inc.(CIL)
  • Avanti Polar Lipids, Inc.
  • Biosolve Chimie
  • BOC Sciences
  • Isolife
  • Atlanchim Pharma
  • Eurisotop
  • Curachem, Inc.
  • CORTECNET SAS
  • Electronic Fluorocarbons, LLC
  • Aanshus Innovative Creations

AI 통합

Global Industry Analysts는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM 및 업계별 SLM 쿼리를 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 중동
  • 아프리카

제4장 경쟁

ksm 25.07.07

Global Stable Isotope Labeled Compounds Market to Reach US$432.5 Million by 2030

The global market for Stable Isotope Labeled Compounds estimated at US$343.5 Million in the year 2024, is expected to reach US$432.5 Million by 2030, growing at a CAGR of 3.9% over the analysis period 2024-2030. Deuterium, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$183.4 Million by the end of the analysis period. Growth in the Oxygen-18 segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$129.0 Million While China is Forecast to Grow at 6.1% CAGR

The Stable Isotope Labeled Compounds market in the U.S. is estimated at US$129.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$33.0 Million by the year 2030 trailing a CAGR of 6.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Stable Isotope Labeled Compounds Market - Key Trends & Drivers Summarized

Stable isotope labeled compounds are critical tools in various scientific and industrial applications, including pharmaceuticals, environmental studies, and metabolic research. These compounds, which are labeled with non-radioactive isotopes like carbon-13, nitrogen-15, oxygen-18, and deuterium, enable researchers to trace and study complex biochemical and chemical processes with high precision. The use of stable isotopes provides detailed insights into reaction mechanisms, metabolic pathways, and drug interactions, significantly advancing our understanding of biological systems and environmental dynamics. Unlike radioactive isotopes, stable isotopes pose no radiation hazard, making them safer and more versatile for extensive use in laboratory and industrial settings.

The market for stable isotope labeled compounds is expanding due to the growing demand in pharmaceutical research and development. These compounds are indispensable in the synthesis and testing of new drugs, where they help in determining the pharmacokinetics and metabolic fate of therapeutic agents. In environmental science, stable isotopes are used to track nutrient cycles, carbon flow, and pollution sources, providing essential data for ecological studies and environmental monitoring. The advent of advanced analytical techniques such as nuclear magnetic resonance (NMR) and mass spectrometry has further amplified the utility of stable isotope labeled compounds, enabling more precise and comprehensive analyses.

The growth in the stable isotope labeled compounds market is driven by several factors. Firstly, the increasing investment in pharmaceutical R&D is boosting the demand for these compounds in drug development and metabolic studies. Secondly, advancements in analytical technologies, such as enhanced sensitivity and resolution in mass spectrometry and NMR, are expanding the applications of stable isotope labeled compounds. Thirdly, the rising focus on environmental sustainability and the need for precise ecological monitoring are driving the use of stable isotopes in environmental research. Lastly, regulatory requirements for detailed metabolic and pharmacokinetic data in drug approval processes are further propelling market growth. These factors collectively contribute to the robust expansion of the stable isotope labeled compounds market.

SCOPE OF STUDY:

The report analyzes the Stable Isotope Labeled Compounds market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Deuterium, Oxygen-18, Carbon-13, Nitrogen-15, Other Types); End-Use (Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 73 Featured) -

  • 3M Company
  • Charles River Laboratories International, Inc.
  • American Elements
  • Bio-Techne Corporation
  • Cambridge Isotope Laboratories, Inc. (CIL)
  • Avanti Polar Lipids, Inc.
  • Biosolve Chimie
  • BOC Sciences
  • Isolife
  • Atlanchim Pharma
  • Eurisotop
  • Curachem, Inc.
  • CORTECNET SAS
  • Electronic Fluorocarbons, LLC
  • Aanshus Innovative Creations

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Tariff Impact on Global Supply Chain Patterns
    • An Introduction to Stable Isotope Labeled Compounds
    • Advantages of Stable Isotope Labeling
    • Radioactive versus Stable Isotopes
    • Global Market Prospects & Outlook
    • Developed Regions Lead, Developing Economies to Fuel Long-term Growth
    • Competition
    • Stable Isotope Labeled Compounds - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Sustained Increase in Research Activities in Pharma and Biotech Sectors Augurs Well for the Market
    • Pharmaceutical R&D Spending Worldwide (USD Billion) for 2015-2025
    • Numerous Benefits of Stable Isotope Labelling in Biochemistry Research Propels Market Prospects
    • Focus on Proteomics Research Presents Growth Opportunities for Stable Isotope Labeled Compounds
    • Global Proteomics Market Revenues (in US$ Million) by Geographic Region/Country for 2020 and 2027
    • Rising Prevalence of Cancer Worldwide Drives Market Growth
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Rising Adoption of PET Scans for Disease Staging to Support Market Prospects
    • Role of Stable Isotopes in Nuclear Industry & Status of Nuclear Reactors Drives Demand for Stable Isotopes
    • Global Electricity Production Breakdown by Source
    • World Installed Nuclear Power Generation Capacity (in GW) for 2020, 2030, 2040 and 2050
    • Rising Importance of Stable Isotopes Human Nutritional Studies
    • Pharmacokinetic and Metabolic Fate of Drugs: Better Understood with Isotopic Labeling of Metabolites
    • Advancements in Deuterium-Labeled Compounds Synthesis
    • Research Study Investigates Metagenomes' Genetic Capacity to Translate into Production of VOCs of Interest
    • Chemical Tagging Stable Isotope Products for Chemical Labeling
    • Stable Isotope Studies Aid in Integration of Non-essential Amino Acids in Pea Aphids
    • Using Stable Isotopes to Measure Denitrification Rates in Soil
    • Use of Stable Isotopically Labeled Benzene to Evaluate Environmental Exposures
    • Stable Isotope Assisted Technique (LC-MS-Based) Offers Better Metabolites Characterization: A Brief Review
    • Growing Role of Stable Isotopes in Animal Migration Research
    • Recent Labelling Advancements in Organic Molecules
    • Creation of Stable Isotope Labeled Internal Standards
    • Mass Spec Internal Standards: Comparing Different Isotopic Labels
    • Use of Stable Labeled Compounds in the form of Internal Standards
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Stable Isotope Labeled Compounds Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Stable Isotope Labeled Compounds by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Stable Isotope Labeled Compounds by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Deuterium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Deuterium by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Deuterium by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Oxygen-18 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Oxygen-18 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Oxygen-18 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Carbon-13 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Carbon-13 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Carbon-13 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Nitrogen-15 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Nitrogen-15 by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Nitrogen-15 by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospitals & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche - Key Competitors in the Canada for 2022 (E)
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Stable Isotope Labeled Compounds by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Stable Isotope Labeled Compounds by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • TABLE 65: France Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • TABLE 83: UK Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Stable Isotope Labeled Compounds Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • TABLE 122: India Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • TABLE 146: Middle East Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Middle East Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Middle East 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 149: Middle East Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Middle East Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Middle East 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • TABLE 152: Africa Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Africa Historic Review for Stable Isotope Labeled Compounds by Type - Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Africa 15-Year Perspective for Stable Isotope Labeled Compounds by Type - Percentage Breakdown of Value Sales for Deuterium, Oxygen-18, Carbon-13, Nitrogen-15 and Other Types for the Years 2015, 2025 & 2030
    • TABLE 155: Africa Recent Past, Current & Future Analysis for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Africa Historic Review for Stable Isotope Labeled Compounds by End-Use - Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Africa 15-Year Perspective for Stable Isotope Labeled Compounds by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies, Academic & Research Institutes, Hospitals & Diagnostic Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제